President Donald Trump signed an executive order to accelerate federal research into ibogaine as a treatment for post-traumatic stress disorder and brain injuries in US veterans.The initiative includes a 50 million dollar federal investment and a new pathway for patient access under the Right To Try rule.Experts from the
FDA will oversee expanded clinical trials to assess safety, specifically addressing risks like heart rhythm disturbances associated with the drug.